Lin Ni
Private Equity Investor bij 6 Dimensions Capital
Actieve functies van Lin Ni
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
6 Dimensions Capital
 6 Dimensions Capital Investment ManagersFinance 6 Dimensions Capital is an independent private equity firm headquartered in China. The firm was founded in 2017. | Private Equity Investor | 18-05-2017 | - |
Loopbaan van Lin Ni
Eerdere bekende functies van Lin Ni
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| GENOR BIOPHARMA HOLDINGS LIMITED | Directeur/Bestuurslid | 23-04-2021 | 29-07-2022 |
| Frontline Bioventures | Directeur/Bestuurslid | - | 18-05-2017 |
Shanghai Ark Biopharmaceutical Co., Ltd.
 Shanghai Ark Biopharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Shanghai Ark Biopharmaceutical Co., Ltd. engages in biopharmaceutical services. It is a biopharmaceutical company which focuses on the discovery and development of novel therapeutics addressing unmet medical needs in respiratory and lung diseases. The firm’s product portfolio covering full disease cycle and patient segmentations, its drug candidates addresses a spectrum of acute and chronic respiratory and lung diseases. The company was founded by Jim Zhen WU and Wu Zheng Bo in April 2014 and is headquartered in Shanghai, China. | Directeur/Bestuurslid | 01-03-2021 | - |
Opleiding van Lin Ni
| Osaka University | Doctorate Degree |
Statistieken
Internationaal
| China | 5 |
| Japan | 2 |
Operationeel
| Director/Board Member | 3 |
| Private Equity Investor | 1 |
| Doctorate Degree | 1 |
Sectoraal
| Finance | 3 |
| Health Technology | 3 |
| Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| GENOR BIOPHARMA HOLDINGS LIMITED | Health Technology |
| Bedrijven in privébezit | 3 |
|---|---|
| Frontline Bioventures | Finance |
6 Dimensions Capital
6 Dimensions Capital Investment ManagersFinance 6 Dimensions Capital is an independent private equity firm headquartered in China. The firm was founded in 2017. | Finance |
Shanghai Ark Biopharmaceutical Co., Ltd.
Shanghai Ark Biopharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Shanghai Ark Biopharmaceutical Co., Ltd. engages in biopharmaceutical services. It is a biopharmaceutical company which focuses on the discovery and development of novel therapeutics addressing unmet medical needs in respiratory and lung diseases. The firm’s product portfolio covering full disease cycle and patient segmentations, its drug candidates addresses a spectrum of acute and chronic respiratory and lung diseases. The company was founded by Jim Zhen WU and Wu Zheng Bo in April 2014 and is headquartered in Shanghai, China. | Health Technology |
